Andover, MA, United States of America

James C Keith, Jr


Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 182(Granted Patents)


Company Filing History:


Years Active: 1996-2009

Loading Chart...
21 patents (USPTO):

Title: Innovative Contributions of James C. Keith, Jr. in Estrogenic Agents

Introduction: James C. Keith, Jr., based in Andover, MA, is a prominent inventor recognized for his significant contributions to the field of pharmaceuticals, particularly in the development of estrogenic agents. With an impressive portfolio of 21 patents, Keith has played a vital role in advancing medical science and improving women's health.

Latest Patents: Among his latest inventions, Keith has developed “Substituted Benzoxazoles as Estrogenic Agents.” This patent presents estrogen receptor modulators defined by a specific structural formula, offering valuable insights into potential therapies for conditions influenced by estrogen. Another noteworthy patent is for “6-Hydroxyequilenins as Estrogenic Agents,” which also focuses on estrogen receptor modulators, showcasing his continued dedication to this critical area of research.

Career Highlights: Throughout his career, Keith has made pivotal contributions while working for well-known organizations such as Wyeth and Genetics Institute, Inc. His research has significantly influenced the development of therapeutic agents that optimize hormonal balance, showcasing his expertise and innovative mindset.

Collaborations: Keith has collaborated with talented individuals in the field, including Heather Anne Harris and Leo M. Albert. These partnerships have facilitated the sharing of knowledge and resources, further enhancing the quality and impact of his inventions.

Conclusion: James C. Keith, Jr. stands out as a distinguished inventor whose innovative work in estrogenic agents is paving the way for advancements in women's health. His dedication to research and collaboration continues to inspire future inventions that may lead to groundbreaking treatments, positioning him as a key player in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…